GoldBamboo.com - Knowledge is strong medicine
  

Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury - Article


  Not Signed In - Sign In / Register






Walking Injuries


Clinical Trial: Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury

This study is currently recruiting patients.
Verified by University of Pittsburgh September 2005

Sponsors and Collaborators: University of Pittsburgh
University of Miami (Florida)
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00148239

Purpose

The overall objective of this project is to test the efficacy of an innovative multi-component intervention aimed at reducing the risk for adverse health outcomes among caregivers of older survivors with spinal cord injury or disability, and to improve the well being of the spinal cord-injured survivor. In a three-group, randomized, controlled design providing access to information, resources, and support, we predict that the dual target approach will have a greater positive impact on both the caregiver and survivor than the caregiver-only approach, and that both active treatments will be superior with respect to caregiver outcomes than an information-only control condition.
Condition Intervention
Spinal Cord Injuries
 Behavior: Education on effects of SCI
 Behavior: Access to local and national SCI-related resources
 Behavior: Intervention sessions on physical/social health
 Behavior: Peer support group discussions

MedlinePlus related topics:  Spinal Cord Injuries

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study

Official Title: Caregiver Intervention for Caregivers of SCI Patients

Further Study Details: 
Primary Outcomes: Mood (survivor and caregiver) (6 and 12 months); Burden (caregiver) (6 and 12 months); Secondary conditions (survivor) (6 and 12 months)
Secondary Outcomes: Knowledge (survivor and caregiver) (6 and 12 months); Social support and social activities (survivor and caregiver) (6 and 12 months); Quality of care (survivor) (6 and 12 months); Safety and mobility (survivor) (6 and 12 months)
Expected Total Enrollment:  432

Study start: September 2002;  Expected completion: June 2007
Last follow-up: January 2007;  Data entry closure: January 2007

The specific aims of this project are to:

  1. Assess the impact of a dual target (caregiver and care recipient) intervention compared to a traditional caregiver-only intervention strategy.
  2. Assess causal linkages between the treatment components (e.g. knowledge, social support) of a multi-component intervention and specific treatment outcomes (e.g. caregiver depression, quality of life).
  3. Explore cultural and racial differences in the evaluation of and effectiveness of the different treatment approaches.

Overall, the issues affecting management of SCI/D in later life are complex and hold critical implications for the health of the long-term survivor as well as for those who provide care in the home environment. Large numbers of individuals are living with the effects of SCI/D for decades post-injury. In addition to the health-related complications that typically accompany older age, these individuals are especially vulnerable to co-occurring medical conditions that require high degrees of support and maintenance. Consequently, older caregivers face multiple and often extreme challenges in providing support to the SCI/D survivor at a time in their lives when their own abilities may be compromised due to age-related changes in health and functioning.

The multi-faceted burden faced by caregivers is associated with high levels of depression and anxiety as well as the onset of deleterious physical symptoms. The cumulative effects of such multiple stressors over time all too frequently leave the caregiver unable to continue providing the level of support necessary to maintain their partner’s health in the home environment. In order to circumvent the additional distress certain to accompany such a family separation, Elliott et al. (2001, p. 230) recently concluded that “there is a pressing need for interventions that help family [SCI] caregivers address the routines and tasks essential to maintaining family functioning.”

Eligibility

Ages Eligible for Study:  30 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria (Survivors):

  • have adult-onset disability resulting from spinal cord injury, trauma, or disease,
  • be survivors with complete or incomplete injury as defined by the American Spinal Injury Association (ASIA) impairment scale
  • require and use some type of assistance for getting around (e.g., wheelchair, cane, etc.) be 30 years old or older be living at home for a minimum of 1 year post-injury (to avoid the acute trauma phase) speak English.

Inclusion Criteria (Caregivers):

  • Is a family member/partner (e.g. spouse, child, or fictive kin)
  • is 18 years of age or older
  • is or is not living with the care recipient
  • speaks English
  • has a telephone at home
  • plans to live in the area for at least 6 months.
  • self-identifies as white, African American or Hispanic.

Exclusion Criteria:

  • has a terminal illness with life expectancy of less than 6 months
  • is in active treatment for cancer (except for tamoxifen and lupron)
  • is blind or deaf
  • if the survivor is cognitively impaired due to brain injury or dementia and/or has no use of their hands and severe limitations in speech production

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00148239

Amy Lustig, PhD      412-624-2078    alustig@ucsur.pitt.edu

Florida
      University of Miami, Miami,  Florida,  33136,  United States; Recruiting
Chin Chin Lee  305-355-9062    clee@med.miami.edu 
Sara Czaja, PhD,  Principal Investigator

Pennsylvania
      University of Pittsburgh (UCSUR), Pittsburgh,  Pennsylvania,  15260,  United States; Recruiting
Amy Lustig, PhD  412-624-2078    alustig@ucsur.pitt.edu 
Richard Schulz, PhD,  Principal Investigator

Study chairs or principal investigators

Richard Schulz, PhD,  Principal Investigator,  University of Pittsburgh   

More Information

Study ID Numbers:  5 R01 NR08272
Last Updated:  September 6, 2005
Record first received:  September 2, 2005
ClinicalTrials.gov Identifier:  NCT00148239
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Walking Injuries.

September 6, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.